English | Español

Biospace
Patient Daily | Jan 12, 2026

Biopharma sector enters 2026 optimistic amid advances in rare disease policy
Patient Daily | Jan 12, 2026

Six major FDA drug decisions expected in early 2026
Patient Daily | Jan 8, 2026

Biopharma industry sees surge in layoffs during challenging year
Patient Daily | Jan 7, 2026

Novo Nordisk launches oral obesity pill; Eli Lilly eyes FDA approval for orforglipron
Patient Daily | Jan 7, 2026

Biohaven ends psychiatric use of BHV-7000 after major depressive disorder trial fails
Patient Daily | Jan 7, 2026

Biotech investors expect rebound by 2026 amid rising deal activity
Patient Daily | Jan 7, 2026

FDA rejects Corcept and Outlook drug applications; stocks fall sharply
Patient Daily | Jan 7, 2026

Big pharma leads Q4 biopharma M&A as smaller biotech deals gain momentum

Trending
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

PhRMA warns of cancer drug markups, 340B program profiteering
+ Pharmaceuticals
Patient Daily | Jan 12, 2026

Six major FDA drug decisions expected in early 2026
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

Big pharma leads Q4 biopharma M&A as smaller biotech deals gain momentum
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

Pfizer leads U.S. drugmakers in planned price increases for 2026